Modafinil, an atypical CNS stimulant?
Melinda Hersey1, Gianluigi Tanda1
1Medication Development Program, NIDA-IRP, NIH, Baltimore, MD, United States.
Advances in Pharmacology (San Diego, Calif.)
|March 11, 2024
Summary
Modafinil, a central nervous system stimulant, shows atypical properties, offering potential benefits for sleep disorders, cognitive dysfunction, and substance use disorders with a low dependence risk.
Area of Science:
- Neuroscience
- Pharmacology
- Psychiatry
Background:
- Modafinil is a central nervous system (CNS) stimulant approved for narcolepsy and sleep disorders.
- Its broad biochemical actions suggest potential therapeutic applications beyond sleep disorders, including cognitive dysfunction and substance use disorders.
- The precise mechanisms of action for modafinil's efficacy remain largely undetermined.
Purpose of the Study:
- To outline the pharmacokinetics and pharmacodynamics of modafinil.
- To highlight the approved and off-label uses of modafinil.
- To explore modafinil's unique pharmacological profile as an atypical CNS stimulant.
Main Methods:
- Review of existing literature on modafinil's pharmacology.
- Analysis of pharmacokinetic and pharmacodynamic data.
- Examination of clinical evidence for therapeutic uses.
Main Results:
- Modafinil inhibits the dopamine transporter, affecting dopamine reuptake.
- Despite similarities to addictive psychostimulants, modafinil exhibits a low incidence of dependence.
- Modafinil has demonstrated efficacy in treating substance use disorders.
- Modafinil influences other neurotransmitter systems (GABA, glutamate, serotonin, norepinephrine) and activates specific brain regions.
Conclusions:
- Modafinil possesses an atypical CNS stimulant profile.
- Its unique pharmacology supports its use in sleep disorders, cognitive enhancement, and substance use disorder treatment.
- Further research into modafinil's complex interactions is warranted to fully understand its therapeutic potential.
Related Concept Videos
01:25Adrenergic Agonists: Indirect-Acting Agents
1.6K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.6K
01:22CNS Stimulants: Psychedelic Agents
151
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
151
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
193
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
193
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
125
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
125
01:23Drugs Acting on Autonomic Ganglia: Stimulants
1.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.3K
01:28Adrenergic Agonists: Mixed-Action Agents
709
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
709